1-19 of 19
Hao Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Lenalidomide, PD-1 Monoclonal Antibodies Combined with Orelabrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase II Study

Lingling Wang, Yongfen Huang, Hui Chen, Hao Xu, Yuexin Cheng, Yuqing Miao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6488.
https://doi.org/10.1182/blood-2024-198309
Published: 2024
Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Qingqing Cai, Yi Xia, Liang Wang, Dongfeng Zeng, Hongyan Tong, Huiqiang Huang, Yuerong Shuang, Zhigang Peng, Ying Zhao, Xiaobo Wang, Xiuhua Sun, Yu Yang, Daoguang Chen, Zhenya Hong, Jinni Wang, Jun Cai, Wei Zhang, Rong Tao, Hong Cen, Jianzhen Shen, Yirong Jiang, Yan Gao, Xiaojie Fang, Man Nie, Xuanye Zhang, Bing Bai, Yuchen Zhang, Qihua Zou, Xi Li, Chunmei Yang, Xin Gao, Hao Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4450.
https://doi.org/10.1182/blood-2024-209224
Published: 2024
Journal Articles

IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy

Zineng Huang, Hao Xu, Qingbai Liu, Jing Li, Keqing Song, Yating Deng, Yujia Tao, Huifang Zhang, Peilong Wang, Heng Li, Yue Sheng, Aijun Zhou, Lianbin Han, Yan Fu, Chenzhi Wang, Saurav Kumar Choudhary, Kaixiong Ye, Gianluca Veggiani, Avery August, Zhihong Li, Weishan Huang, Qiang Shan, Hongling Peng, Zheng Fu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3411.
https://doi.org/10.1182/blood-2024-201942
Published: 2024
Journal Articles

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Suning Chen, Yanli Zhang, Na Xu, Hui Sun, Li Weiming, Yunfan Yang, Zunmin Zhu, Minghui Duan, Sixuan Qian, Yu Zhu, Jianmin Luo, Xiaodong Wang, Wei Yang, Weiying Gu, Fei Li, Bingcheng Liu, Yunxiao Xu, Zhenfang Liu, Chunling Wang, Yirong Jiang, Li Meng, Qin Wen, Yanli Xu, Xingli Zou, Wei Wang, Yan Xue, Hao Xu, Kehong Bi, Fuling Zhou, Liangming Ma, Rong Fu, Guifang Ouyang, Kaiyang Ding, Depei Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1797.
https://doi.org/10.1182/blood-2023-179073
Published: 2023
Journal Articles

Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Miao Qing, Yongfen Huang, Can Chen, Lingling Wang, Jun Feng, Chuanhai Xu, Yuexin Cheng, Jianming Dong, Linlin Zhang, Hao Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3769–3770.
https://doi.org/10.1182/blood-2022-167998
Published: 2022
Journal Articles

High Efficacy of Azacitidine Plus Hag in Acute Myeloid Leukemia: A Multi-Center, Phase 2 Clinical Trial

Jun Li, Qi Han, Yanqing Huang, Yanhui Wei, Jie Zi, Lidong Zhao, Zhimei Cai, Xuzhang Lu, Rong Xiao, Yanmin Zhang, Xiaotian Yang, Hao Xu, Naitong Sun, Wanchuan Zhuang, Zhengdong Wu, Yuan Xia, Yanli Xu, Bin He, Wei Zhu, Fengling Min, Yongchun Chen, Banghe Ding, Peimin Shi, Jing Xie, Hua Tang, Zefa Liu, Bingzong Li, Yu Sun, Hongxia Qiu, Limin Duan, Chunhua Song, Zheng Ge
Journal: Blood
Blood (2022) 140 (Supplement 1): 6167–6169.
https://doi.org/10.1182/blood-2022-164649
Published: 2022
Journal Articles

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

Clinical Trials & Observations
Wenyue Cao, Jia Wei, Na Wang, Hao Xu, Min Xiao, Lifang Huang, Yang Cao, Chunrui Li, Yi Xiao, Chaojiang Gu, Shangkun Zhang, Dengju Li, Yichen Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Journal: Blood
Blood (2020) 136 (4): 516–519.
https://doi.org/10.1182/blood.2020004907
Published: 2020
Includes: Supplemental data
Journal Articles

Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation

Brief Report
Hao Xu, Nancy J. Wandersee, YiHe Guo, Deron W. Jones, Sandra L. Holzhauer, Madelyn S. Hanson, Evans Machogu, David C. Brousseau, Neil Hogg, John C. Densmore, Sushma Kaul, Cheryl A. Hillery, Kirkwood A. Pritchard, Jr
Journal: Blood
Blood (2014) 124 (26): 3978–3981.
https://doi.org/10.1182/blood-2014-04-560813
Published: 2014
Includes: Supplemental data
Journal Articles

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193

Matthew D. Seftel, MDMPH FRCPC, John Kuruvilla, MD, Versha Banerji, MD, Graeme Fraser, MDFRCPC, Hao Xu, MSc, Jean Powers, MSc, Susan Crocker, PhD, Marcia Toguchi, PhD, John F Lyons, PhD, Lesley Seymour, MDPhD, Annette E Hay, MB ChB
Journal: Blood
Blood (2014) 124 (21): 5670.
https://doi.org/10.1182/blood.V124.21.5670.5670
Published: 2014
Journal Articles

A Phase II Study of AT9283, an Aurora Kinase Inhibitor, in Patients with Relapased or Refractory Multiple Myloma; NCIC Clinical Trials Group IND.191

Annette E Hay, MB ChB, Alli Murugesan, PhD, Ashley M. DiPasquale, BSc, Tom Kouroukis, MD MSc, FRCPC, Irwindeep Sandhu, MD FRCPC, Vishal Kukreti, MD, Nizar J Bahlis, MD, Johan Lategan, MD, Donna E. Reece, MD, John F. Lyons, PhD, Joana Sederias, MSc, Jean Powers, MSc, Hao Xu, MSc, Lesley K. Seymour, MD PhD FRCP (C), Anthony Reiman, MD
Journal: Blood
Blood (2014) 124 (21): 5734.
https://doi.org/10.1182/blood.V124.21.5734.5734
Published: 2014
Journal Articles

HMGB1 Release and TLR4-Mediated Inflammation In Sickle Cell Disease At Baseline and During Acute Vaso-Occlusive Crisis

Hao Xu, PhD, Nancy J. Wandersee, PhD, YiHe H. Guo, PhD, Deron W. Jones, Sandra L. Holzhauer, Madelyn S. Hanson, PhD, Neil Hogg, PhD, John C. Densmore, MD, Sushma Kaul, MS, Cheryl A. Hillery, MD, Kirkwood A. Pritchard, Jr., PhD
Journal: Blood
Blood (2013) 122 (21): 181.
https://doi.org/10.1182/blood.V122.21.181.181
Published: 2013
Journal Articles

The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations

Gang Huang, Xinghui Zhao, Lan Wang, Shannon Elf, Hao Xu, Xinyang Zhao, Goro Sashida, Yue Zhang, Yan Liu, Jennifer Lee, Silvia Menendez, Youyang Yang, Xiaomei Yan, Pu Zhang, Daniel G. Tenen, Motomi Osato, James J.-D. Hsieh, Stephen D. Nimer
Journal: Blood
Blood (2011) 118 (25): 6544–6552.
https://doi.org/10.1182/blood-2010-11-317909
Published: 2011
Includes: Supplemental data
Journal Articles

Methylation of RUNX1 by the Nuclear PRMT5/COPR5 Complex Regulates Its Cellular Location in Leukemia Cells,

Xinyang Zhao, Ph.D., Ly P. Vu, Fabiana Perna, MD, Fan Liu, MD, Hao Xu, Stephen Nimer
Journal: Blood
Blood (2011) 118 (21): 3403.
https://doi.org/10.1182/blood.V118.21.3403.3403
Published: 2011
Journal Articles

A Novel Hemoglobin Binding Peptide Increases Intracellular Heme and Potentiates Hemoglobin-Induced HO-1 Levels in Endothelial Cells

Madelyn S. Hanson, PhD, Timothy C. Flewelen, Hao Xu, PhD, Kirkwood A Pritchard, Jr., PhD, Nancy J Wandersee, PhD, Neil Hogg, PhD, Cheryl A. Hillery, MD
Journal: Blood
Blood (2011) 118 (21): 1065.
https://doi.org/10.1182/blood.V118.21.1065.1065
Published: 2011
Journal Articles

The Acetylation of AML1-ETO Is Required for Leukemogenesis.

Lan Wang, PhD, Alexander Gural, MD, Fabiana Perna, MD, Xiaojian Sun, PhD, Xinyang Zhao, PhD, Haiming Xu, PhD, Megan A Hatlen, Gang Huang, Ph.D., Fan Liu, PhD, Hao Xu, MD, Tony Deblasio, Silvia Menendez, Francesca Voza, Robert Roeder, PhD, Stephen Nimer, MD
Journal: Blood
Blood (2010) 116 (21): 1588.
https://doi.org/10.1182/blood.V116.21.1588.1588
Published: 2010
Journal Articles

A Novel Hemoglobin-Binding Agent Reduces Plasma Free Hemoglobin and Partially Improves Vascular Function In Murine Hemolytic Anemia

Nancy J. Wandersee, PhD, Timothy C. Flewelen, Anne C. Frei, Deron W. Jones, Dawn Retherford, Sandra L. Holzhauer, Soumya Gokuli, Madelyn S. Hanson, PhD, Cheryl A. Hillery, MD, Neil Hogg, PhD, Kirkwood A. Pritchard, Jr., PhD, Hao Xu, Ph.D
Journal: Blood
Blood (2010) 116 (21): 267.
https://doi.org/10.1182/blood.V116.21.267.267
Published: 2010
Journal Articles

D-4F Restores eNOS-Dependent Vasodilation in Sickle Cell Disease by Decreasing Proinflammatory HDL.

Kirkwood A. Pritchard, Jr., Jingli Wang, Hao Xu, Deron W. Jones, Sandra L. Holzhauer, Thomas D. Foster, Keith T. Oldham, Cheryl A. Hillery
Journal: Blood
Blood (2005) 106 (11): 2324.
https://doi.org/10.1182/blood.V106.11.2324.2324
Published: 2005
Journal Articles

Differential Effects of Lovastatin and Allopurinol Therapy in a Murine Model of Sickle Cell Disease.

Kirkwood A. Pritchard, Jr., Terri L. Besch, Jingli Wang, Hao Xu, Deron W. Jones, Thomas D. Foster, Sandra L. Holzhauer, Keith T. Oldham, Nancy J. Wandersee, Cheryl A. Hillery
Journal: Blood
Blood (2005) 106 (11): 2325.
https://doi.org/10.1182/blood.V106.11.2325.2325
Published: 2005
Journal Articles

Interleukin-6–Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway

Feng-hao Xu, Sanjesh Sharma, Agnes Gardner, Yiping Tu, Arthur Raitano, Charles Sawyers, Alan Lichtenstein
Journal: Blood
Blood (1998) 92 (1): 241–251.
https://doi.org/10.1182/blood.V92.1.241.413k28_241_251
Published: 1998